GSK
Website:
GSK
Index:
FTSE 100
EPIC: GSK
Supersector:
Health Care
Sector:
Pharmaceuticals and Biotechnology
Subsector:
Pharmaceuticals
Market Cap:
£77.51B
Payout Frequency: Quarterly
GSK Annual Dividend Yield - 3.54%
Dividends Used in Calculation:
| Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 13/11/2025 |
08/01/2026 |
Q3 |
16.0000p |
GBX |
| 19/02/2026 |
09/04/2026 |
Q4 |
18.0000p |
GBX |
| 14/05/2026 |
09/07/2026 |
Q1 |
17.0000p |
GBX |
| 13/08/2026 |
08/10/2026 |
Q2 |
17.0000p |
GBX |
Total (Annual Dividends Per Share):
68.00p
Dividend Yield =
Annual Dividends Per Share (68.00p)
÷ Share Price (1920.5p)
= 3.54%
GSK Dividend History
| Ex Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 13/08/2026 |
08/10/2026 |
Q2 |
17.0000p |
GBX |
| 14/05/2026 |
09/07/2026 |
Q1 |
17.0000p |
GBX |
| 19/02/2026 |
09/04/2026 |
Q4 |
18.0000p |
GBX |
| 13/11/2025 |
08/01/2026 |
Q3 |
16.0000p |
GBX |
| 14/08/2025 |
09/10/2025 |
Q2 |
16.00p |
GBX |
| 15/05/2025 |
10/07/2025 |
Q1 |
16.00p |
GBX |
| 20/02/2025 |
10/04/2025 |
Q4 |
16.00p |
GBX |
| 14/11/2024 |
09/01/2025 |
Q3 |
15.00p |
GBX |
| 15/08/2024 |
10/10/2024 |
Q2 |
15.00p |
GBX |
| 16/05/2024 |
11/07/2024 |
Q1 |
15.00p |
GBX |
| 22/02/2024 |
11/04/2024 |
Q4 |
16.00p |
GBX |
| 16/11/2023 |
11/01/2024 |
Q3 |
14.00p |
GBX |
| 17/08/2023 |
12/10/2023 |
Q2 |
14.00p |
GBX |
| 18/05/2023 |
13/07/2023 |
Q1 |
14.00p |
GBX |
| 23/02/2023 |
13/04/2023 |
Q4 |
13.75p |
GBX |
| 17/11/2022 |
12/01/2023 |
Q3 |
13.75p |
GBX |
| 18/08/2022 |
06/10/2022 |
Q2 |
16.25p |
GBX |
| 19/05/2022 |
01/07/2022 |
Q1 |
14.00p |
GBX |
| 24/02/2022 |
07/04/2022 |
Q4 |
23.00p |
GBX |
| 18/11/2021 |
13/01/2022 |
Q3 |
19.00p |
GBX |
| 19/08/2021 |
07/10/2021 |
Q2 |
19.00p |
GBX |
| 20/05/2021 |
08/07/2021 |
Q1 |
19.00p |
GBX |
| 18/02/2021 |
08/04/2021 |
Q4 |
23.00p |
GBX |
| 12/11/2020 |
14/01/2021 |
Q3 |
19.00p |
GBX |
| 13/08/2020 |
08/10/2020 |
Q2 |
19.00p |
GBX |
| 14/05/2020 |
09/07/2020 |
Q1 |
19.00p |
GBX |
| 20/02/2020 |
09/04/2020 |
Q4 |
23.00p |
GBX |
| 14/11/2019 |
09/01/2020 |
Q3 |
19.00p |
GBX |
| 08/08/2019 |
10/10/2019 |
Q2 |
19.00p |
GBX |
| 16/05/2019 |
11/07/2019 |
Q1 |
19.00p |
GBX |
| 21/02/2019 |
11/04/2019 |
Q4 |
23.00p |
GBX |
| 15/11/2018 |
10/01/2019 |
Q3 |
19.00p |
GBX |
| 09/08/2018 |
11/10/2018 |
Q2 |
19.00p |
GBX |
| 10/05/2018 |
12/07/2018 |
Q1 |
19.00p |
GBX |
| 22/02/2018 |
12/04/2018 |
Q4 |
23.00p |
GBX |
| 09/11/2017 |
11/01/2018 |
Q3 |
19.00p |
GBX |
| 10/08/2017 |
12/10/2017 |
Q2 |
19.00p |
GBX |
| 11/05/2017 |
13/07/2017 |
Q1 |
19.00p |
GBX |
| 23/02/2017 |
13/04/2017 |
Q4 |
23.00p |
GBX |
| 03/11/2016 |
12/01/2017 |
Q3 |
19.00p |
GBX |
| 11/08/2016 |
13/10/2016 |
Q2 |
19.00p |
GBX |
| 12/05/2016 |
14/07/2016 |
Q1 |
19.00p |
GBX |
| 18/02/2016 |
14/04/2016 |
Q4 |
23.00p |
GBX |
| 18/02/2016 |
14/04/2016 |
Special |
20.00p |
GBX |
| 12/11/2015 |
14/01/2016 |
Q3 |
19.00p |
GBX |
| 13/08/2015 |
01/10/2015 |
Q2 |
19.00p |
GBX |
| 14/05/2015 |
09/07/2015 |
Q1 |
19.00p |
GBX |
| 19/02/2015 |
09/04/2015 |
Q4 |
23.00p |
GBX |
| 06/11/2014 |
08/01/2015 |
Q3 |
19.00p |
GBX |
| 06/08/2014 |
02/10/2014 |
Q2 |
19.00p |
GBX |
| 14/05/2014 |
10/07/2014 |
Q1 |
19.00p |
GBX |
| 19/02/2014 |
10/04/2014 |
Q4 |
23.00p |
GBX |
| 13/11/2013 |
09/01/2014 |
Q3 |
19.00p |
GBX |
| 07/08/2013 |
03/10/2013 |
Q2 |
18.00p |
GBX |
| 08/05/2013 |
11/07/2013 |
Q1 |
18.00p |
GBX |
| Year |
Special |
Currency |
Total |
Change |
| 2024 |
|
GBX |
61.000 |
9.410 |
| 2023 |
|
GBX |
55.750 |
-16.790 |
| 2022 |
|
GBX |
67.000 |
-16.250 |
| 2021 |
|
GBX |
80.000 |
0.000 |
| 2020 |
|
GBX |
80.000 |
0.000 |
| 2019 |
|
GBX |
80.000 |
0.000 |
| 2018 |
|
GBX |
80.000 |
0.000 |
| 2017 |
|
GBX |
80.000 |
-20.000 |
| 2016 |
20.000 |
GBX |
100.000 |
25.000 |
| 2015 |
|
GBX |
80.000 |
0.000 |
| 2014 |
|
GBX |
80.000 |
45.450 |
| 2013 |
|
GBX |
55.000 |
|
GSK Dividend Calculator
GSK Dividend Growth
| Dividend Growth (1Y) |
7.94%
|
| Dividend CAGR (5Y) |
-7.42%
|
| Years of Growth |
2
|
| Payout Ratio |
55.3%
|
| Buyback Yield |
1.36%
|
| Shareholder Yield |
5.18%
|
| P/E Ratio (TTM) | 16.3 |
| Forward P/E | 10.37 |
| P/FCF | 11.16 |
| Earnings Yield | 6.26% |
| FCF Yield | 8.96% |
| ROE | 33.38% |
| ROCE | 24.09% |
| Profit Margin | 14.52% |
| Operating Margin | 29.17% |
| Gross Margin | 73.49% |